[Genetic testing in the context of the revision of the French law on bioethics].
This article focuses on six questions raised by genetic testing in human: (1) the use of genetic tests, (2) information given to relatives of patients affected with genetic disorders, (3) prenatal and preimplantatory diagnosis for late onset genetic diseases and the use of pangenomic tests in prenatal diagnosis, (4) direct-to-consumer genetic testing, (5) population screening in the age of genomic medicine and (6) incidental findings when genetic testing are used.
Bonneau
D
D
Inserm U 694, Service de Génétique, CHU d'Angers, 4 rue Larrey, 49933 Angers cedex 9, France. dobonneau@chu-angers.fr
Marlin
S
S
Sanlaville
D
D
Dupont
J-M
JM
Sobol
H
H
Gonzales
M
M
Le Merrer
M
M
Malzac
P
P
Razavi
F
F
Manouvrier
S
S
Odent
S
S
Stoppa-Lyonnet
D
D
D003219:Confidentiality / Q000941:ethics / Q000331:legislation & jurisprudence; D005192:Family Health; D005260:Female; D005602:France; D005820:Genetic Testing / Q000941:ethics / Q000331:legislation & jurisprudence*; D006801:Humans; D008297:Male; D011247:Pregnancy; D019836:Preimplantation Diagnosis / Q000941:ethics; D011296:Prenatal Diagnosis / Q000941:ethics; D012648:Self Care